[Pneumococcal Meningitis in Spanish Children: Incidence, Serotypes and Antibiotic Resistance. Prospective and Multicentre Study]
Overview
Authors
Affiliations
Objective: To determine the incidence, as well as the implicated serotypes and patterns of antibiotic resistance of Streptococcus pneumoniae meningitis in Spanish children.
Material And Method: We performed a prospective, multicenter study in five Autonomous Communities (Catalonia, Galicia, Madrid, Navarre and the Basque Country) for 1 year (1 February 2000 31 January 2001). All children aged 0-14 years with pneumococcal meningitis from all the hospitals in the Autonomous Communities studied were included. Diagnosis was based on clinical findings and isolation of S. pneumoniae in the cerebrospinal fluid/blood using routine methods or polymerase chain reaction. Serotyping was performed using the guellung reaction and/or immunoblotting and susceptibility to antibiotics was evaluated by the technique of agar dilution. The pediatric population aged 0-14 years in the Autonomous Communities studied comprises 2,290,304 children.
Results: Fifty-two cases were identified. One patient was aged less than 2 months old, 25 (48 %) were aged 2-12 months, and 12 patients (23 %) were aged 12-24 months. The annual incidence per 100,000 children aged between 1 and 2 years was 17.75 cases (95 % CI: 11.59 26.01) and 8.39 cases (95 % CI: 4.67 15.79) respectively, and that for children in the first 2 and 5 years of life was 13.13 (95 % CI: 9.29 18.02) and 6.29 (95 % CI: 4.57 8.,45) cases respectively. Nearly half the strains isolated (47.6 %) showed reduced sensitivity to penicillin. The most frequent serotype was 19F (12 cases [28.6 %]). Eighty percent of the isolated serotypes were included in the formula of the heptavalent conjugate vaccine.
Conclusions: The incidence of pneumococcal meningitis in children from five Spanish Autonomous Communities is high, nearly twice that found in a prior retrospective studied performed in the same population 1-3 years previously. Almost all the isolated serotypes were included in the heptavalent conjugate vaccine. Half the strains showed reduced sensitivity to penicillin.
Imohl M, Moller J, Reinert R, Perniciaro S, van der Linden M, Aktas O BMC Infect Dis. 2015; 15:61.
PMID: 25885764 PMC: 4335684. DOI: 10.1186/s12879-015-0787-1.
PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis.
Avni T, Mansur N, Leibovici L, Paul M J Clin Microbiol. 2009; 48(2):489-96.
PMID: 20007385 PMC: 2815606. DOI: 10.1128/JCM.01636-09.
Aristegui J, Bernaola E, Pocheville I, Garcia C, Arranz L, Duran G Eur J Clin Microbiol Infect Dis. 2007; 26(5):303-10.
PMID: 17457623 DOI: 10.1007/s10096-007-0294-4.
Burden of paediatric invasive pneumococcal disease in Europe, 2005.
McIntosh E, Fritzell B, Fletcher M Epidemiol Infect. 2006; 135(4):644-56.
PMID: 16959054 PMC: 2870618. DOI: 10.1017/S0950268806007199.
Clinical data and factors associated with poor outcome in pneumococcal meningitis.
Casado-Flores J, Aristegui J, de Liria C, Martinon J, Fernandez C Eur J Pediatr. 2005; 165(5):285-9.
PMID: 16333641 DOI: 10.1007/s00431-005-0024-9.